Goldman Sachs Raises WellPoint PT To $75 (WLP)

Goldman Sachs raised its WellPoint WLP price target from $70 to $75 in a research report published today. In the report, Goldman Sachs states, "Our increased 2011 EPS primarily reflects WLP's view of higher revenue for 2011 being driven by robust member growth, changes in product mix, and strong pricing (with a flow-through in our model to 2012). WLP mapped out a credible 2011 outlook that seems conservative with EPS guidance continuing to be “at least $6.30” and a $59.5 bn op. revenue target (3% yoy growth following a 5% decline last year)." WellPoint shares were at $64.98 in Wednesday after hours trading, up 0.08% from Wednesday's market close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsGoldman SachsHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!